Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Method of Treating Obesity, Insulin Resistance, Non-Alcoholic Fatty Liver Disease Including Non-Alcoholic Steatohepatitis

  • Read more about Method of Treating Obesity, Insulin Resistance, Non-Alcoholic Fatty Liver Disease Including Non-Alcoholic Steatohepatitis
US Application 62/465,009
Filed on 2017-02-28

CHIMERIC ANTIGEN RECEPTORS AND THEIR USES

  • Read more about CHIMERIC ANTIGEN RECEPTORS AND THEIR USES
US Application 62/506,268
Filed on 2017-05-15

Phenyl Indole Allosteric Inhibitors Of P97 ATPase

  • Read more about Phenyl Indole Allosteric Inhibitors Of P97 ATPase
US Application 62/244,497
Filed on 2015-10-21

Human Monoclonal Antibodies Against FLT3 and Uses Thereof

  • Read more about Human Monoclonal Antibodies Against FLT3 and Uses Thereof
US Application 62/437,547
Filed on 2016-12-21

ANTI-MAGE-A3/A6 ANTIBODIES, POLYPEPTIDES, AND PROTEINS

  • Read more about ANTI-MAGE-A3/A6 ANTIBODIES, POLYPEPTIDES, AND PROTEINS
US Application 62/425,231
Filed on 2016-11-22

METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT

  • Read more about METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT
US Application 62/418,461
Filed on 2016-11-07

Synergistic Anti-Tumor Effect of HMG Protein in Combination with Anti-CD4 Antibody or Immune Checkpoint Regulator

  • Read more about Synergistic Anti-Tumor Effect of HMG Protein in Combination with Anti-CD4 Antibody or Immune Checkpoint Regulator
US Application 62/385,588
Filed on 2016-09-09

Glypican 2 As A Cancer Marker And Therapeutic Target

  • Read more about Glypican 2 As A Cancer Marker And Therapeutic Target
US Application 62/253,000
Filed on 2015-11-09

IL-6 And IL-17A As Classifiers Of Lung Cancer Mortality For Stage I Adenocarcinoma

  • Read more about IL-6 And IL-17A As Classifiers Of Lung Cancer Mortality For Stage I Adenocarcinoma
US Application 62/412,690
Filed on 2016-10-25

Functionally-interdependent Shape-switching Nucleic Acid Anticubes and Other Nanoparticles

  • Read more about Functionally-interdependent Shape-switching Nucleic Acid Anticubes and Other Nanoparticles
US Application 62/480,899
Filed on 2017-04-03

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 79
  • Page 80
  • Page 81
  • Page 82
  • Page 83
  • Page 84
  • Page 85
  • Page 86
  • Page 87
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health